Phase II trial of taxol in salivary gland malignancies (E1394): A trial of the Eastern Cooperative Oncology Group
- 7 February 2006
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 28 (3), 197-204
- https://doi.org/10.1002/hed.20327
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Salivary gland tumoursOral Diseases, 2002
- Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignanciesCancer, 2001
- Cancers of the upper aerodigestive tract in Ontario, Canada, and the United StatesCancer, 2000
- Adenoid cystic carcinoma of the head and neckClinical Otolaryngology, 1997
- Relationship of Mitotic Arrest and Apoptosis to Antitumor Effect of PaclitaxelJNCI Journal of the National Cancer Institute, 1996
- Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patientsCancer, 1991
- Cisplatin-based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neckCancer, 1988
- Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland originCancer, 1987
- Adenocarcinoma of salivary origin: Clinicopathologic study of 204 patientsThe American Journal of Surgery, 1982
- Adriamycin/cis-platinum/cyclophosphamide combination chemotherapy for advanced carcinoma of the parotid glandCancer, 1981